Biohaven (BHVN) Stock Price, Quote, News & History | Benzinga

Biohaven Ltd (BHVN) Stock Price, Quote, News & History

BHVNNYSE

Trade with Public

Trade with Public

$14.64

-0.21-1.41%

At close: Aug 13, 5:00 PM EST

$14.85

N/A

Pre-Market: 7:44 AM EST

Earnings: Q2 2026 Earnings were released on Mon Aug 10th, after the market close

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$14.64

Volume / Avg.

1.00 / 2.81M

Day Range

- - -

52 Wk Range

7.48 - 18.57

Market Cap

$2.24B

P/E Ratio

-

Dividend Yield

-

Exchange

NYSE

RSI

53

Short Interest

15.4%

Days to Cover

9.27

Recent Biohaven Ltd. News

ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday

US stocks lower, Nasdaq falls 400 pts. ManpowerGroup shares rise after upbeat earnings. Other big gainers: PHOE, SG, TRVI, DCBO, ZNTL, GPRE, SLS, FEIM, TRV, BHVN, KOS, BJRI, MBX.

Avi Kapoor

Analyst Warns Biohaven's Lead Drug May Struggle To Stand Out

Biohaven (BHVN) shares fall as BofA downgrades the stock to Underperform, citing a risky profile ahead of key epilepsy trial data.

Vandana Singh

Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

US stock futures up, Nasdaq 100 gains 1%. Biohaven (BHVN) shares down after BofA downgrade and enrollment of first patient in phase 3 trial.

Avi Kapoor

What's Going On With Biohaven Stock On Monday?

Biohaven shares rose in premarket trading after Xenon's Phase 3 epilepsy study showed strong seizure reduction results.

Vandana Singh

This Albemarle Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-511.40M

Investing Cash Flow (TTM)

211.26M

Financing Cash Flow (TTM)

371.73M

Free Cash Flow (TTM)

-511.87M

Capital Expenditure (TTM)

-475.00K

Net Change in Cash (TTM)

71.60M

Analyst Trends and Forecast

2

1

Mar

1

Apr

2

1

May

1

Jun

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.24B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

180.93

Earnings Yield % (TTM)

-31.08%

Earnings Yield % (FWD)

-21.86%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.08

Company Debt

Total Debt

$259.48M

LT Debt

$259.48M

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-

Total Cash

$238.03M

Debt to Equity

24.30

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$14.64

Volume / Avg.

1.00 / 2.81M

Day Range

- - -

52 Wk Range

7.48 - 18.57

Market Cap

$2.24B

P/E Ratio

-

Dividend Yield

-

Exchange

NYSE

RSI

53

Short Interest

15.4%

Days to Cover

9.27

About

Sector

Health Care

Industry

Biotechnology

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline inclu...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Biohaven (BHVN) stock?

A

You can purchase shares of Biohaven (NYSE:BHVN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Biohaven (BHVN) competitors?

A

Other companies in Biohaven’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Biohaven (BHVN) stock?

A

Biohaven has a consensus price target of $33.50.

Q

What is the current price for Biohaven (BHVN)?

A

The stock price for Biohaven (NYSE: BHVN) is $14.85 last updated August 14, 2026 at 6:33 PM EDT.

Q

Does Biohaven (BHVN) pay a dividend?

A

There are no upcoming dividends for Biohaven.

Q

When is Biohaven (NYSE:BHVN) reporting earnings?

A

Biohaven does not have any upcoming earnings scheduled.

Q

Is Biohaven (BHVN) going to split?

A

There is no upcoming split for Biohaven.

Q

What sector and industry does Biohaven (BHVN) operate in?

A

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.